A case of acute encephalopathy manifested with impaired consciousness, hemichorrhea, speech and cognitive impairment in a female patient with COVID-19 and multiple sclerosis is presented. In the literature, there are isolated reports of such a combination of diseases, and therefore difficulties arise in carrying out differential diagnosis and prescribing therapy. Given the limited knowledge about the long-term consequences of COVID-19, systematic analysis of such cases and follow-up of such patients is necessary.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17116/jnevro2024124041159 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introduction Mucormycosis is an uncommon fungal infection caused by filamentous fungi of the Mucorales order, namely Rhizopus, Lichthemia, andMucor species. The incidence and prevalence of mucormycosis reached an all-time high during the COVID-19 pandemic due to excessive steroid use and other factors, leading to the coining of the term CAM (COVID Associated Mucormycosis). The diagnosis of mucormycosis is by a combination of histopathology and microbiological techniques, such as KOH mount and culture.
View Article and Find Full Text PDFOsteoarticular mucormycosis of the distal femur in a post COVID-19 patient.
Med Mycol Case Rep
December 2024
Orthopaedics, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India.
Article Synopsis
- - A 38-year-old man with no prior health issues experienced pain and swelling in his knee after recovering from severe COVID-19, leading to the discovery of Mucorales fungal infection in his femur, maxillary sinus, and right lung.
- - The infection required a combined surgical approach that included an above-knee amputation, debridement of the left maxillary sinus, and removal of the lower lobe of the right lung to reduce the fungal load.
- - The case emphasizes the importance of prompt imaging and surgical intervention for fungal infections in individuals with weakened immune systems to improve outcomes.
Meningococcal Pneumonia in a Patient With Pulmonary Amyloidosis and a Recent COVID-19 Infection.
Cureus
September 2024
Respiratory Medicine, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, JPN.
Article Synopsis
- A 64-year-old man with a history of pulmonary amyloidosis and recent COVID-19 presented with high fever and throat pain, indicating potential bronchopneumonia.
- Imaging revealed thickened bronchial walls, left upper lobe infiltrates, and existing pulmonary nodules.
- Despite the patient's complex medical background, treatment led to a favorable outcome, highlighting the risks of rare infections in individuals with weakened immune systems.
Coronavirus disease (COVID-19), which broke out in China and caused a devastating pandemic worldwide, is associated with a significantly increased risk of thrombotic complications, especially pulmonary embolism. During the COVID-19 pandemic, investigations have reported a high incidence of venous thromboembolic (VTE) events in hospitalized patients with COVID-19, often despite thromboprophylaxis. Current recommendations for thromboprophylaxis are based on randomized clinical trials, which usually exclude patients at а potentially high risk of hemorrhagic complications.
View Article and Find Full Text PDFCoronavirus disease (COVID-19) has been associated with a diverse range of extrapulmonary manifestations since its global outbreak in 2019. One of its rare complications is Guillain-Barre Syndrome (GBS), a post-infectious neurological disorder that manifests with a characteristic ascending limb paralysis. Here, we describe the atypical case of a 42-year-old African American male who developed bilateral facial paralysis within five weeks of testing positive for COVID-19.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!